Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age

Published:2000-02 Issue:15 Volume:18 Page:1456-1466
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

de Kleijn Ester D,de Groot Ronald,Labadie Jerry,Lafeber Arianne B,van den Dobbelsteen Germie,van Alphen Loek,van Dijken Harry,Kuipers Betsy,van Omme Gijs-Willem,Wala Mayke,Juttmann Ricardo,Rümke Hans C

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference50 articles.

1. van der Ende A, Spanjaard L, Dankert J. Bacterial meningitis in the Netherlands. Annual report 1996. Amsterdam: University of Amsterdam: Reference Laboratory for Bacterial Meningitis (AMC, RIVM), 1996.

2. Appearance of new strains associated with group B meningococcal disease and their use for rapid vaccine development;Frasch;Antonie Van Leeuwenhoek,1987

3. Immunologic response of man to group B meningococcal polysaccharide vaccine;Wyle;J. Infect. Dis.,1972

4. Human immunoglobin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain;Azmi;Infect. Immun.,1995

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose Determination and Administration of Bacterial Extracellular Vesicles for In Vivo Preclinical Studies;Methods in Molecular Biology;2024

2. Promising pharmaceutical development of vaccines for the prevention of meningococcal infection;Journal of microbiology, epidemiology and immunobiology;2023-09-21

3. Bacterial extracellular vesicles and their interplay with the immune system;Pharmacology & Therapeutics;2023-07

4. Bacterial extracellular vesicle applications in cancer immunotherapy;Bioactive Materials;2023-04

5. Carriers and Antigens: New Developments in Glycoconjugate Vaccines;Vaccines;2023-01-19